Narcolepsy: genetic predisposition and neuropharmacological mechanisms: REVIEW ARTICLE

This publication has 99 references indexed in Scilit:

• The treatment of accessory symptoms in narcolepsy: a double-blind cross-over study of a selective serotonin re-uptake inhibitor (femoxetine) versus placebo
  Acta Neurologica Scandinavica, 2009
• Neuropharmacological Characterization of Basal Forebrain Cholinergic Stimulated Cataplexy in Narcoleptic Canines
  Experimental Neurology, 2002
• HLA class II analysis in Jewish Israeli narcoleptic patients
  Human Immunology, 1995
• Effects of Modafinil on Symptomatology of Human Narcolepsy
  Clinical Neuropharmacology, 1993
• Narcolepsy without unique MHC class II antigen association: Studies in the canine model
  Human Immunology, 1989
• Problems and Coping Strategies Identified by Narcoleptic Patients
  Journal of Neuroscience Nursing, 1984
• Narcolepsy: Cholinergic receptor changes in an animal model
  Life Sciences, 1984
• Activity of substantia nigra units across the sleep-waking cycle in freely moving cats
  Neuroscience Letters, 1981
• The central stimulatory action of inhibitors of the dopamine uptake
  Life Sciences, 1979
• Electroencephalographic analyses of amphetamine and its methoxy derivatives with reference to their sites of EEG alerting in the rabbit brain
  International Journal of Neuropharmacology, 1969